An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus

Virologica Sinica

Volumn 27, Issue 6, 2012, Pages 373-376

  Nanda, Raj Kishore ^a   Edao, Bedaso Mammo ^a   Hajam, Irshad Ahmad ^a   Sekar, Shanmugam Chandra ^a   Ganesh, Kondabattula ^a   Bhanuprakash, Veerakyathappa ^a   Kishore, Subodh ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; NANOPARTICLE; OUTER MEMBRANE PROTEIN A; PLASMID DNA;

ANTIBODY TITER; DNA IMMUNIZATION; DNA VECTOR; DRUG DELIVERY SYSTEM; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; LETTER; NONHUMAN; OMPA GENE; PARTICLE SIZE; SWINE; VIRUS INACTIVATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHITOSAN; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNOGLOBULIN G; NANOPARTICLES; NEUTRALIZATION TESTS; VACCINES, DNA;

EID: 84875144473     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-012-3269-2     Document Type: Letter

References (17)

1. Apostolopoulos V, Xiang S D, Selomulya C, et al. 2010. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2(3): 205-218.
2. Bozkir A, Saka O M. 2004. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv, 11: 107-112. (Pubitemid 38437079)
3. Centelles M N, Qian C, Campanero M A, et al. 2008. New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles. Int J Nanomed, 3(4): 451-460.
4. Chinsangaram J, Beard C, Mason P W, et al. 1998. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol, 72: 4454-4457. (Pubitemid 28188756)
5. Doel T R, 2003. FMD Vaccines. Virus Res, 91: 81-89. (Pubitemid 36078432)
6. Hashimoto M, Morimoto M, Saimoto H, et al. 2006. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnol Lett, 28: 815-821. (Pubitemid 43926904)
7. Jang M K, Jeong Y I, Cho C S, et al. 2002. The preparation and characterization of low molecular and water soluble free-amine chitosan. Bull Korean Chem Soc, 23: 914-916.
8. Jiang H L, Kang M L, Quan J S, et al. 2008. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization, Biomaterials, 29: 1931-1939.
9. Jiang L, Qian F, He X, et al. 2007. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. J Gene Med, 9: 253-264. (Pubitemid 46746316)
10. Kim T H, Jin H, Kim H W, et al. 2006. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther, 5: 1723-1732. (Pubitemid 44323240)
11. Lu S, Song X, Cao D, et al. 2004. Preparation of Water-Soluble Chitosan. J Appl Polymer Sci, 91: 3497-3503. (Pubitemid 38287205)
12. McCullough K C, Sobrino F. 2004. Immunology of Foot and Mouth Disease. In: Foot and Mouth Disease current perspectives. Sobrino F, Domingo E, Ed. England: Horizon Bioscience, pp173-222.
13. Mady M M, Darwish M M, Khalil S, et al. 2009. Biophysical studies on chitosan coated liposomes. Eur Biophysic J, 38: 1127-1133.
14. OIE Manual. 2008. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter No.2.1.5. (Revised version May 2012), 6th Edition, Volume 1 and 2.
15. Reed L J, Muench H A. 1938. A simple method of estimating 50% end points. Am J Hyg, 27: 493-497.
16. Tan M C, Mommaas A M, Drijfhout J W, et al. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol, 27: 2426-2435. (Pubitemid 27404330)
17. Zhao F, Wu Y, Zhang X, et al. 2011. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2. Hum Vaccine. 1: 7(10).